SCHEMBL5199838

SCHEMBL5199838

CCc1ncc(C=CC(=O)O)[nH]1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.45
BLM P54132 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
CYP3A4 P08684 1/20 0.45
TSHR P16473 1/20 0.45
RAB9A P51151 3/20 0.41
NPC1 O15118 3/20 0.41
KMT2A Q03164 2/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.41
P4HTM Q9NXG6 1/20 0.39
ALDH1A1 P00352 6/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
HPGD P15428 2/20 0.36
MITF O75030 1/20 0.36
KLF5 Q13887 1/20 0.36
PAK4 O96013 1/20 0.35
MAPK1 P28482 1/20 0.34
MAP3K7 O43318 1/20 0.34
TAB1 Q15750 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5199832 1.00 KDM4E (0.45) KDM4EBLMNPSR1CYP3A4TSHR
Fumaric Acid SCHEMBL28937802 0.78 HCAR2 (0.36) KDM4EBLMNPSR1CYP3A4TSHR
SCHEMBL889049 0.77 KDM4E (0.49) KDM4EBLMNPSR1CYP3A4TSHR
SCHEMBL18782927 0.75 KDM4E (0.50) KDM4EBLMNPSR1CYP3A4TSHR
SCHEMBL9267228 0.70 CA12 (0.42) KDM4ECYP3A4RAB9ANPC1KMT2A
SCHEMBL4506135 0.69 PIN1 (0.46) KDM4EBLMSMN1; SMN2HCAR2
SCHEMBL8740568 0.69 PIN1 (0.54) KDM4EBLMNPSR1CYP3A4TSHR
SCHEMBL2998701 0.67 KDM4E (0.41) KDM4EBLMNPSR1CYP3A4TSHR
SCHEMBL20308844 0.66 NPSR1 (0.41) KDM4EBLMNPSR1CYP3A4TSHR
SCHEMBL10661608 0.66 P4HTM (0.62) KDM4ECYP3A4TSHRRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1790636-A1 PIPERIDINE DERIVATIVES AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2007-05-30 EP disclosed
US-20060142337-A1 Piperidine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-06-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060142337-A1 Piperidine derivative and use thereof AR, AHR, ARNT KDM4E 1123/4885BLM 2788/4885NPSR1 908/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.